Labcorp Holdings Inc. logo
Labcorp Holdings Inc. (LH)
Compare

Labcorp Holdings Inc. (LH) Free Cash Flow Yield: 6.27%

Is Labcorp Holdings Inc.’s free cash flow yield high or low?

Labcorp Holdings Inc.'s free cash flow yield of 6.27% is 13% below its 5-year average of 7.19%, near the low end of its 5-year range (3.32%–13.32%).

As of Sunday, June 14, 2026. 8.49% above its 12-month average of 5.78%.

LH Free Cash Flow Yield Chart

LH Free Cash Flow Yield
6.27%+20.11% 1Y
Zoom

LH Average Free Cash Flow Yield Chart

LH Current vs Average Free Cash Flow Yield Chart

LH Free Cash Flow Yield Metrics

FREE CASH FLOW YIELD

6.27%

FREE CASH FLOW YIELD AVG TTM

5.78%

FREE CASH FLOW YIELD AVG 3Y

5.24%

FREE CASH FLOW YIELD AVG 5Y

7.19%

FREE CASH FLOW YIELD AVG 10Y

7.24%

FREE CASH FLOW YIELD AVG 15Y

7.42%

FREE CASH FLOW YIELD AVG 20Y

7.80%

CURRENT VS TTM AVG

+8.49%

CURRENT VS 3Y AVG

+19.67%

CURRENT VS 5Y AVG

-12.76%

CURRENT VS 10Y AVG

-13.45%

CURRENT VS 15Y AVG

-15.49%

CURRENT VS 20Y AVG

-19.57%

LH Competitors' Free Cash Flow Yield

NAMEMARKET CAPFREE CASH FLOW YIELDTTM3Y5Y
Labcorp Holdings Inc. (LH)$21.83B6.27%5.78%5.24%7.19%
Mettler-Toledo International Inc. (MTD)$22.86B3.46%3.21%3.24%2.88%
BioNTech SE (BNTX)$22.90B6.53%3.88%18.83%19.77%
United Therapeutics Corporation (UTHR)$23.17B3.95%5.29%5.80%5.83%
Waters Corporation (WAT)$23.17B0.90%2.81%2.67%2.70%
Moderna, Inc. (MRNA)$19.80BN/A8.49%9.09%9.09%
Veeva Systems Inc. (VEEV)$25.92B6.21%3.61%3.10%2.76%
Hologic, Inc. (HOLX)$16.97B5.82%6.28%5.68%7.87%
DexCom, Inc. (DXCM)$29.08B4.82%3.35%2.09%1.41%
Biogen Inc. (BIIB)$29.53B8.83%9.18%6.94%6.70%

Yield Comparison

FCF Yield

6.27%

Earnings Yield

4.24%

Dividend Yield

1.08%

Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100

How FCF Yield is used:

  • Shows free cash flow after capital expenditures relative to market cap
  • Can be compared with earnings yield and dividend yield
  • Can be compared with the company's historical range
  • Can be compared with peers that report positive free cash flow

FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.

Labcorp Holdings Inc. Free Cash Flow Yield Formula & Definition

FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Labcorp Holdings Inc. Free Cash Flow Yield FAQ

What is the free cash flow yield for Labcorp Holdings Inc. (LH)?
The free cash flow yield for LH stock is 6.27%.
Is Labcorp Holdings Inc.'s free cash flow yield high or low?
Labcorp Holdings Inc.'s free cash flow yield of 6.27% is 13% below its 5-year average of 7.19%, near the low end of its 5-year range (3.32%–13.32%).
What is the TTM average free cash flow yield for Labcorp Holdings Inc. (LH)?
The TTM average free cash flow yield for LH stock is 5.78%.
What is the 3Y average free cash flow yield for Labcorp Holdings Inc. (LH)?
The 3Y average free cash flow yield for LH stock is 5.24%.
What is the 5Y average free cash flow yield for Labcorp Holdings Inc. (LH)?
The 5Y average free cash flow yield for LH stock is 7.19%.
What is the 10Y average free cash flow yield for Labcorp Holdings Inc. (LH)?
The 10Y average free cash flow yield for LH stock is 7.24%.
What is the 15Y average free cash flow yield for Labcorp Holdings Inc. (LH)?
The 15Y average free cash flow yield for LH stock is 7.42%.
What is the 20Y average free cash flow yield for Labcorp Holdings Inc. (LH)?
The 20Y average free cash flow yield for LH stock is 7.80%.

Labcorp Holdings Inc. Free Cash Flow Yield History

DATEFREE CASH FLOW YIELD
2026-06-126.27%
2026-06-116.29%
2026-06-106.22%
2026-06-096.15%
2026-06-086.37%
2026-06-056.30%
2026-06-046.40%
2026-06-036.45%
2026-06-026.48%
2026-06-016.50%
2026-05-296.42%
2026-05-286.35%
2026-05-276.46%
2026-05-266.46%
2026-05-226.42%
2026-05-216.53%
2026-05-206.49%
2026-05-196.58%
2026-05-186.53%
2026-05-156.67%
2026-05-146.57%
2026-05-136.56%
2026-05-126.49%
2026-05-116.54%
2026-05-086.57%
2026-05-076.47%
2026-05-066.50%
2026-05-056.49%
2026-05-046.60%
2026-05-015.67%
2026-04-305.64%
2026-04-295.64%
2026-04-285.58%
2026-04-275.50%
2026-04-245.49%
2026-04-235.47%
2026-04-225.32%
2026-04-215.30%
2026-04-205.39%
2026-04-175.36%
2026-04-165.44%
2026-04-155.43%
2026-04-145.39%
2026-04-135.49%
2026-04-105.56%
2026-04-095.31%
2026-04-085.28%
2026-04-075.39%
2026-04-065.28%
2026-04-025.30%
2026-04-015.31%
2026-03-315.43%
2026-03-305.50%
2026-03-275.49%
2026-03-265.40%
2026-03-255.45%
2026-03-245.45%
2026-03-235.48%
2026-03-205.51%
2026-03-195.49%
2026-03-185.45%
2026-03-175.36%
2026-03-165.43%
2026-03-135.49%
2026-03-125.51%
2026-03-115.36%
2026-03-105.39%
2026-03-095.30%
2026-03-065.38%
2026-03-055.25%
2026-03-045.16%
2026-03-035.12%
2026-03-025.06%
2026-02-275.01%
2026-02-265.04%
2026-02-255.13%
2026-02-245.05%
2026-02-235.78%
2026-02-205.84%
2026-02-195.84%
2026-02-185.92%
2026-02-175.96%
2026-02-135.84%
2026-02-125.93%
2026-02-115.69%
2026-02-105.80%
2026-02-096.02%
2026-02-065.95%
2026-02-055.93%
2026-02-045.97%
2026-02-036.06%
2026-02-026.11%
2026-01-306.08%
2026-01-296.11%
2026-01-286.15%
2026-01-276.09%
2026-01-266.17%
2026-01-236.19%
2026-01-226.11%
2026-01-216.13%
2026-01-206.08%
2026-01-166.09%
2026-01-156.13%
2026-01-146.30%
2026-01-136.49%
2026-01-126.59%
2026-01-096.55%
2026-01-086.48%
2026-01-076.50%
2026-01-066.34%
2026-01-056.51%
2026-01-026.56%
2025-12-316.57%
2025-12-306.52%
2025-12-296.52%
2025-12-266.50%
2025-12-246.49%
2025-12-236.51%
2025-12-226.47%
2025-12-196.54%
2025-12-186.54%
2025-12-176.45%
2025-12-166.39%
2025-12-156.27%
2025-12-126.25%
2025-12-116.23%
2025-12-106.30%
2025-12-096.39%
2025-12-086.35%
2025-12-056.39%
2025-12-046.31%
2025-12-036.21%
2025-12-026.20%
2025-12-016.16%
2025-11-286.14%
2025-11-266.15%
2025-11-256.11%
2025-11-246.22%
2025-11-216.21%
2025-11-206.31%
2025-11-196.33%
2025-11-186.35%
2025-11-176.31%
2025-11-146.18%
2025-11-136.16%
2025-11-126.20%
2025-11-116.15%
2025-11-106.32%
2025-11-076.53%
2025-11-066.69%
2025-11-056.58%
2025-11-046.54%
2025-11-036.40%
2025-10-316.50%
2025-10-305.95%
2025-10-296.05%
2025-10-285.78%
2025-10-275.44%
2025-10-245.37%
2025-10-235.28%
2025-10-225.31%
2025-10-215.28%
2025-10-205.16%
2025-10-175.25%
2025-10-165.29%
2025-10-155.31%
2025-10-145.36%
2025-10-135.42%
2025-10-105.40%
2025-10-095.40%
2025-10-085.41%
2025-10-075.36%
2025-10-065.46%
2025-10-035.42%
2025-10-025.37%
2025-10-015.38%
2025-09-305.23%
2025-09-295.31%
2025-09-265.35%
2025-09-255.43%
2025-09-245.37%
2025-09-235.36%
2025-09-225.38%
2025-09-195.41%
2025-09-185.41%
2025-09-175.43%
2025-09-165.47%
2025-09-155.45%
2025-09-125.40%
2025-09-115.36%
2025-09-105.50%
2025-09-095.39%
2025-09-085.41%
2025-09-055.39%
2025-09-045.45%
2025-09-035.48%
2025-09-025.48%
2025-08-295.40%
2025-08-285.45%
2025-08-275.37%
2025-08-265.39%
2025-08-255.43%
2025-08-225.39%
2025-08-215.43%
2025-08-205.39%
2025-08-195.44%
2025-08-185.55%
2025-08-155.55%
2025-08-145.53%
2025-08-135.50%
2025-08-125.57%
2025-08-115.61%
2025-08-085.64%
2025-08-075.77%
2025-08-065.75%
2025-08-055.69%
2025-08-045.69%
2025-08-015.74%
2025-07-315.25%
2025-07-305.18%
2025-07-295.22%
2025-07-285.22%
2025-07-255.16%
2025-07-245.10%
2025-07-235.46%
2025-07-225.42%
2025-07-215.62%
2025-07-185.61%
2025-07-175.53%
2025-07-165.56%
2025-07-155.56%
2025-07-145.47%
2025-07-115.47%
2025-07-105.39%
2025-07-095.27%
2025-07-085.31%
2025-07-075.30%
2025-07-035.22%
2025-07-025.25%
2025-07-015.17%
2025-06-305.21%
2025-06-275.24%
2025-06-265.32%
2025-06-255.28%
2025-06-245.21%
2025-06-235.24%
2025-06-205.22%
2025-06-185.23%
2025-06-175.27%
2025-06-165.18%
2025-06-135.23%
2025-06-125.22%
2025-06-115.26%
2025-06-105.27%
2025-06-095.34%
2025-06-065.38%
2025-06-055.42%
2025-06-045.37%
2025-06-035.46%
2025-06-025.51%

Showing the most recent 260 of 5,033 data points. The chart above shows the full history.

About Labcorp Holdings Inc.

Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.

Burlington, NC
60,900 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Adam H. Schechter